This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| OCADO GROUP PLC | 1,300.0 | 6.1% |
| INTL CONSOLIDATED AIRLINE-DI | 175.0 | 4.7% |
| ITV PLC | 119.8 | 4.3% |
| ADMIRAL GROUP PLC | 3,074.0 | 4.0% |
| ANTOFAGASTA PLC | 1,290.0 | 3.9% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| EVRAZ PLC | 445.0 | -3.5% |
| AIRTEL AFRICA PLC | 139.1 | -1.8% |
| SAINSBURY (J) PLC | 277.4 | -1.5% |
| STANDARD CHARTERED PLC | 563.0 | -1.5% |
| GLAXOSMITHKLINE PLC | 1620.8 | -1.4% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,643 | 1.0% | 17.2% |
| DOW JONES INDUS. AVG | 35,768 | 0.9% | 13.8% |
| DAX INDEX | 15,482 | 1.6% | 11.1% |
| NIKKEI 225 | 27,696 | 0.4% | -6.3% |
| S&P/ASX 200 INDEX | 7,288 | 0.3% | 6.3% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 89.47 | -0.21% |
| Brent Crude (ICE) | USD/bbl. | 91.27 | -0.31% |
| Gold Spot | USD/t oz. | 1,835 | 0.1% |
| Copper (Comex) | USd/lb. | 464 | 0.8% |
Click graph to enlarge
The UK 100 is called to open +5 points today at 7650. A marginally higher open is expected this morning for UK markets, continuing the strong performance we have seen this week. Asian markets were mixed on Thursday as the Reserve Bank of India’s governor announced that the repo rate will remain unchanged at 4%. Japan’s Nikkei advanced 0.42% to 27,696 and South Korea’s Kospi rose 0.21% to 2775. The Shanghai Composite in China fell 0.15% to 3,475 while Hong Kong’s Hang Seng slipped 0.19% to 24,782. The picture was positive on Wall Street yesterday as tech shares led a broad rally, clawing back some of their losses after a rough start to the year. The Nasdaq jumped 2.08% to close at 14,490.37. The S&P gained 1.5% to 4,587.18, while the Dow Jones rose 305.28 points, or 0.86%, to close at 35,768.06.
Ashmore report that their assets under management on Dec 31st was at $87.3bn, down 8% during H1. Their H1 pretax profit came in at £116m, down 23% YoY.
AstraZeneca have forecast higher 2022 sales after the drugmaker posted better-than-expected Q4 profit as it gets a lift from its COVID-19 antibody treatment. They did warn that its gross profit margin from coronavirus products is expected to be lower than the company average for this year, while sales are expected to decline by low-to-mid twenties percentage.
Babcock International agrees to sell 15% stake in AirTanker to Equitix for £95m.
Prudential announces that CEO Mike Wells will retire at the end of March and will be replaced by Mark Fitzpatrick on an interim basis.
Rolls-Royce completes sales of 23% stake in AirTanker to Equitix for £189m cash. They plan to use proceeds to rebuild balance sheet and boost credit profile.
Unilever reported Q4 sales growth of 4.9% (beating average analyst forecasts of 3.8%) as people ate more at home. They expect their underlying sales growth in 2022 to be in the range of 4.5-6.5%. Pricing will continue to be strong, with some impact on volume as a result.
Watches of Switzerland expects FY revenue and profit to be at top end of previous guidance.
Ashmore Group
AstraZeneca
Beazley
RELX
Redrow
Royal Mail Group
Tate & Lyle
Unilever
British American Tobacco
Electrocomponents
European Commission releases Economic Growth Forecasts
UK NIESR GDP Estimate
US Consumer Price Index
US Initial Jobless Claims
US Monthly Budget Statement
FTSE 100:
FTSE 250:
Aberforth Smaller Companies Trust
Greencoat UK Wind
Endeavour Mining
LXi REIT
UK Commercial Property REIT
Henderson Smaller Cos Inv Tst
Virgin Money UK
ICG Enterprise Trust
BMO Commercial Property Trust
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.